RSI Extremes Signal Potential Reversals and Sustained Momentum

Today's market exhibits a significant number of stocks at Relative Strength Index (RSI) extremes, signaling potential inflection points for institutional investors. While historically high or low RSI readings often precede mean reversion, strong underlying catalysts can sustain momentum, demanding careful analysis beyond simple technical indicators.

The Relative Strength Index (RSI) is a momentum oscillator measuring the speed and change of price movements. Readings above 70 typically indicate an overbought condition, suggesting a stock may be ripe for a pullback, while readings below 30 signal an oversold state, hinting at a potential bounce. However, in robust trends, stocks can remain in overbought or oversold territory for extended periods, making the identification of catalysts crucial.

Among the overbought cohort, UnitedHealth Group (UNH) stands out with an RSI of 97, driven by a strong Q1 2026 earnings beat, exceeding EPS and revenue forecasts, and an increased full-year adjusted EPS outlook. The company also announced a $2 billion share repurchase program and benefited from a better-than-expected 2.48% Medicare Advantage reimbursement increase for 2027. Analyst sentiment is largely positive, with a consensus 'Strong Buy' rating. Similarly, QUALCOMM (QCOM), with an RSI of 93, has seen its stock surge due to reports of collaboration with OpenAI and Microsoft on AI-focused smartphone processors, coupled with a Q2 2026 earnings beat and a massive $20 billion share buyback authorization. Centene (CNC), at an RSI of 92, has rallied on a Q1 earnings beat, improved medical-cost controls, and a more favorable 2.48% net average increase in 2027 Medicare Advantage payment policies, which flipped the narrative from 'Medicare squeeze' to a 'better-than-feared reset'. Nucor (NUE), sporting an RSI of 91, has benefited from strong Q1 2026 earnings, robust steel demand, higher realized prices, and supportive U.S. trade policy, including Section 232 tariffs, creating one of the most favorable import environments in decades. These overbought stocks are trading significantly above their 50-day and 200-day simple moving averages, confirming strong upward trends that, while extended, are supported by fundamental tailwinds. Investors should be wary of potential profit-taking, but acknowledge the power of these underlying catalysts.

Conversely, the oversold list presents opportunities for discerning investors. Tractor Supply Company (TSCO), with an RSI of 9, has seen its stock decline despite reporting solid Q1 2026 financial results, including a 3.6% increase in net sales and reaffirming its fiscal year 2026 outlook. The company recently announced a 32% reduction in email marketing costs through a partnership, aiming for greater efficiency. Lockheed Martin (LMT), at an RSI of 11, experienced a nine-day losing streak after a disappointing Q1 2026 earnings report, missing EPS and revenue expectations, and reporting negative free cash flow. This overshadowed positive catalysts like a $4.7 billion PAC-3 MSE interceptor contract and a substantial backlog. Northrop Grumman (NOC) and RTX Corporation (RTX), with RSIs of 13 and 19 respectively, are also in oversold territory. While RTX raised its full-year adjusted sales and EPS outlook after a strong Q1, the stock still slipped, suggesting investors are re-evaluating valuation and costs. PG&E Corporation (PCG), with an RSI of 16, has seen its stock impacted by lingering wildfire liability concerns despite exceeding Q1 2026 earnings expectations and the approval of a 20-year license renewal for its Diablo Canyon Power Plant. These oversold stocks are still trading above their 50-day and 200-day moving averages, indicating that while they are experiencing short-term weakness, the longer-term trend may still be intact. While the allure of 'catching a falling knife' is strong, investors should prioritize a clear reversal signal or a stabilization in the underlying fundamentals before committing capital.